Cognitive decline reversed by cinacalcet.

نویسندگان

  • H J Wallace
  • I R Wallace
  • P McCaffrey
چکیده

An 85-year-old lady with decreased mood and low energy was found to have an elevated serum corrected calcium concentration of 2.8mmol/L (reference range: 2.1–2.6mmol/L). Plasma parathyroid hormone concentration was elevated at 390 pg/mL (reference range: 10–85 pg/mL). She had a past history of renal calculi. Renal function, full blood picture, erythrocyte sedimentation rate, 24-h urinary calcium excretion, serum immunoglobulins, chest X-ray and serum angiotensin converting enzyme concentrations were all normal. Myeloma screening was negative. Serum-corrected calcium concentrations fell following rehydration. A thiazide diuretic was discontinued. A sestamibi scan (Figure 1) was unhelpful in pre-operative localization. The patient declined parathyroidectomy. One year later, she was admitted with dehydration with serum-corrected calcium concentration elevated at 2.93mmol/L. This did not reduce in response to rehydration or diuretic therapy and had a minimal reduction with intravenous bisphosphonates. Mini Mental State Examination (MMSE) score was 21/30 and serum-corrected calcium was 2.85 nmol/L on discharge. Vitamin D concentration was low at 19 nmol/L (reference range: 50–100 nmol/L). She was not commenced on Vitamin D replacement. The following day, she presented with marked confusion, abdominal pain and decreased responsiveness. CT scan of brain showed no acute changes. ECG was normal, and there were no signs of systemic infection. MMSE was 6/30, and serum-corrected calcium concentration was 2.92mmol/L. Over the following 12 days, calcium did not reduce in response to repeated infusions of intravenous bisphosphonates. Her functional status had deteriorated and she was now fully dependent in all activities of daily living. Nursing home placement was being advanced by the family and social services. A trial of the calcimimetic agent cinacalcet was commenced at a dose of 30mg twice daily. Within 4 weeks, her serumcorrected calcium concentration was 2.15mmol/L, MMSE was 26/30 and mood and functional status had improved (Figure 2). This lady has now returned to independent living and remains on a maintenance dose of cinacalcet 30mg twice daily.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD

BACKGROUND Secondary hyperparathyroidism (sHPT) represents an adaptive response to progressively impaired control of calcium, phosphorus and vitamin D in chronic kidney disease (CKD). It is characterized by parathyroid hyperplasia and excessive synthesis and secretion of parathyroid hormone (PTH). Parathyroid hyperplasia in uremic rats can be prevented by calcium-sensing receptor (CaSR) activat...

متن کامل

Renal function in patients treated with cinacalcet for persistent hyperparathyroidism after kidney transplantation.

BACKGROUND AND AIM Cinacalcet effectively reduces calcium in patients with persistent hyperparathyroidism (HPT) after kidney transplantation. We aimed to assess the association of cinacalcet with a decrease in renal function based on a meta-analysis of observational studies in kidney transplant patients with persistent HPT. METHOD Meta-analysis of observational studies, no randomized controll...

متن کامل

Development and validation of a chiral liquid chromatographic method for determination of S-isomer in cinacalcet API

A reversed phase enantioselective high performance liquid chromatographic method was developed and validated for determination ofS-enantiomer in Cinacalcet drug substance. The enantiomers of Cinacalcet were resolved on a Chiralcel-OJH (250mmx4.6mm, 5microns) column using a mobile phase system containing n-Hexane, ethanol and n-butyl amine (90:10:1). The resolution between enantiomers was found ...

متن کامل

Development and Validation of a Stability-Indicating RP-UPLC Method for the Estimation of Impurities in Cinacalcet Hydrochloride API and its Formulation.

A sensitive, stability-indicating, gradient reversed-phase ultra-performance liquid chromatography method has been developed for the quantitative estimation of cinacalcet hydrochloride impurities in active pharmaceutical ingredients and pharmaceutical formulations. Efficient chromatographic separation was achieved on an Acquity BEH Shield RP18, 100 × 2.1 mm, 1.7 µm column with the mobile phase ...

متن کامل

Cinacalcet Treatment of Primary Hyperparathyroidism

Although parathyroidectomy remains the only curative approach to most primary hyperparathyroidism cases, medical treatment with cinacalcet HCl has been proven to be a reasonable alternative for several patient subgroups. Cinacalcet almost always controls hypercalcemia and hypophosphatemia sufficiently. PTH levels are lowered, and cognitive parameters improve. While an increase in bone mineral d...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • QJM : monthly journal of the Association of Physicians

دوره 108 1  شماره 

صفحات  -

تاریخ انتشار 2015